Skip to main content
. Author manuscript; available in PMC: 2011 Apr 10.
Published in final edited form as: Life Sci. 2010 Feb 14;86(15-16):624–630. doi: 10.1016/j.lfs.2010.02.013

Figure 3.

Figure 3

Summary graphs of antagonist effects in the locomotor assay. Nalmefene was approximately equipotent to naloxone in blocking the locomotor stimulating effects of a fixed dose of morphine (panel A, 95% confidence intervals overlap). When given at supramaximal doses (1 mg/kg, i.p.), neither antagonist produced a significant effect on locomotor activity compared to vehicle treated mice (panel B, p > 0.05).